Expanded Access:18F-Fluorocholine for the Detection of Parathyroid Adenomas
ConditionParathyroid Adenomas
Trial statusAvailable
Trial phaseNot listed
Trial typeExpanded Access
Biological sexAll
Age13+
SponsorThomas Hope
About this trial
This expanded access protocol is proposed to allow University of California San Francisco (UCSF) patients additional access to 18F-fluorocholine (FCH) Positron Emission Tomography (PET) imaging for localization of parathyroid adenomas.
Eligibility criteria
Qualifiers
Age ≥ 13 years.
Evidence of primary hyperparathyroidism.
Ability to understand a written informed consent document, and the willingness to sign it.
Disqualifiers
None
Trial design
Treatments tested in this trial
- 18F-Fluorocholine (FCH)
- Positron emission tomography (PET)
Treatment groups
No treatment groups listed
Locations
Sponsors and collaborators
Thomas Hope
Lead sponsor
University of California, San Francisco
Sponsor institution
Source ClinicalTrials.gov